Packard, C. J. (2017) Unpacking and understanding the impact of proprotein convertase subtilisin/kexin type 9 inhibitors on apolipoprotein B metabolism. Circulation, 135(4), pp. 363-365. (doi: 10.1161/CIRCULATIONAHA.116.025897) (PMID:28115413)
|
Text
136242.pdf - Accepted Version 505kB |
Abstract
No abstract available.
| Item Type: | Articles (Editorial) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Packard, Professor Chris |
| Authors: | Packard, C. J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Circulation |
| Publisher: | American Heart Association |
| ISSN: | 0009-7322 |
| ISSN (Online): | 1524-4539 |
| Published Online: | 23 January 2017 |
| Copyright Holders: | Copyright © 2017 American Heart Association, Inc. |
| First Published: | First published in Circulation 135(4):363-365 |
| Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details